Versatility of cell-penetrating peptides for intracellular delivery of siRNA

Drug Deliv. 2018 Nov;25(1):1996-2006. doi: 10.1080/10717544.2018.1543366.

Abstract

The plasma membrane is a large barrier to systemic drug delivery into cells, and it limits the efficacy of drug cargo. This issue has been overcome using cell-penetrating peptides (CPPs). CPPs are short peptides (6-30 amino acid residues) that are potentially capable of intracellular penetration to deliver drug molecules. CPPs broadened biomedical applications and provide a means to deliver a range of biologically active molecules, such as small molecules, proteins, imaging agents, and pharmaceutical nanocarriers, across the plasma membrane with high efficacy and low toxicity. This review is focused on the versatility of CPPs and advanced approaches for siRNA delivery.

Keywords: Cell-penetrating peptides; cellular internalization; conjugation; gene therapy; siRNA delivery.

Publication types

  • Review

MeSH terms

  • Cell Membrane / metabolism*
  • Cell-Penetrating Peptides / metabolism*
  • Drug Delivery Systems
  • Genetic Therapy*
  • Humans
  • RNA, Small Interfering / administration & dosage*

Substances

  • Cell-Penetrating Peptides
  • RNA, Small Interfering

Grants and funding

This work was supported by the Korea Institute of Energy Technology Evaluation and Planning (KETEP) and the Ministry of Trade, Industry & Energy (MOTIE) of the Republic of Korea (No. 20184030202130). This work was also supported by the Soonchunhyang University.